With a series of new business wins and extending its team with six new appointments, the agency says that it has bolstered its creative, development, performance and strategy divisions.

Since the start of the year, Rogerwilco has added United States-based health sciences company SYNAPS Dx, as well as Mweb, one of South Africa’s leading ISPs, to its client roster.

According to the agency, SYNAPS Dx has developed the world’s first diagnostic skin test to identify Alzheimer's disease and distinguish it from other forms of dementia. 

"Our brief is to assist with a full digital campaign, encompassing strategy, web build, social and performance media as well as content marketing to raise awareness of the business and its DISCERNTM test across key US markets," says Rogerwilco’s Charlie Stewart.

Frank Amato, CEO of SYNAPS Dx, adds, "Prior to the pandemic, we’d likely have restricted our search for an agency to the US. But, new ways of working have opened our eyes to the possibilities of remote partnerships."

"We’re delighted to have found an agency that can not only deliver with the same level of strategic rigour and agility as any in the US, but also enables us to take advantage of Africa’s lower cost production base," Amato says.

For Mweb, the agency has been tasked with helping the ISP with its content marketing efforts with a view to improving customer experience and engagement with its self-service products.

Stewart concludes, "While we’ve benefited from brands’ rapid shift to digital over the past couple of years, it’s been particularly gratifying to see an increasing number of local and international organisations entrusting us with their marketing budgets. Ultimately, this is at the heart of Rogerwilco — generating quantifiable results for our clients with creativity, passion and purpose."

For more information, visit www.rogerwilco.co.za. You can also follow Rogerwilco on Facebook or on Twitter.